People with type 1 or type 2 diabetes have a slightly increased risk of infectious diseases compared to people without diabetes. This is particularly the case if diabetes management is not optimal and blood glucose levels are too high over the long term. It is important for people with diabetes to measure tissue or blood glucose levels several times a day. The generally recommended target range for long-term blood glucose (HbA1c value) is 6.5 to 7.5 percent (47.5 to 58.5 mmol/mol).
Based on the findings to date, the DDG assumes that people with diabetes who have well-controlled blood glucose levels and no accompanying or secondary diseases are not at higher risk than with a conventional flu virus. However, if one or more diabetes-related concomitant and secondary diseases such as cardiovascular disease or organ damage are present, the risk of a severe course of COVID-19 is increased.
Information on Corona and Diabetes
You can find detailed information on the topic of "Corona and Diabetes" and answers to important questions on the diabetes information portal diabinfo (www.diabinfo.de) at
https://www.diabinfo-leben.de/coronavirus-sars-cov-2.html
Further information offers (in German)
The RKI provides general, daily situation reports and coronavirus case numbers as well as a current risk assessment for the disease COVID-19:
The Federal Centre for Health Education (BZgA) provides additional information on the coronavirus SARS-CoV-2 as well as health education videos and hygiene tips:
Sufficient supply of medication is guaranteed
Supply shortages for diabetes medicines are not to be feared now and in the future, the DDG emphasized. Insulin is also produced in Germany. The Federal Institute for Drugs and Medical Devices (BfArM) also does not expect short-term supply shortages of medication due to the coronavirus. The Institute is continuously monitoring and evaluating the situation.
Since insulin is produced in Germany, among other countries, supply bottlenecks for diabetes drugs are not to be expected, the DDG emphasized. The Federal Institute for Drugs and Medical Devices (BfArM) also has no fear that there might be a shortage of drugs for people with diabetes due to the coronavirus.